Cargando…
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390228/ https://www.ncbi.nlm.nih.gov/pubmed/35994565 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.058294 |
| _version_ | 1784770606418362368 |
|---|---|
| author | Cosentino, Francesco Cannon, Christopher P. Frederich, Robert Cherney, David Z.I. Dagogo-Jack, Samuel Pratley, Richard E. Mancuso, James P. Maldonado, Mario Cater, Nilo B. Wang, Shuai McGuire, Darren K. |
| author_facet | Cosentino, Francesco Cannon, Christopher P. Frederich, Robert Cherney, David Z.I. Dagogo-Jack, Samuel Pratley, Richard E. Mancuso, James P. Maldonado, Mario Cater, Nilo B. Wang, Shuai McGuire, Darren K. |
| author_sort | Cosentino, Francesco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9390228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93902282022-08-26 Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial Cosentino, Francesco Cannon, Christopher P. Frederich, Robert Cherney, David Z.I. Dagogo-Jack, Samuel Pratley, Richard E. Mancuso, James P. Maldonado, Mario Cater, Nilo B. Wang, Shuai McGuire, Darren K. Circulation Correspondence Lippincott Williams & Wilkins 2022-08-23 2022-08-23 /pmc/articles/PMC9390228/ /pubmed/35994565 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.058294 Text en © 2022 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
| spellingShingle | Correspondence Cosentino, Francesco Cannon, Christopher P. Frederich, Robert Cherney, David Z.I. Dagogo-Jack, Samuel Pratley, Richard E. Mancuso, James P. Maldonado, Mario Cater, Nilo B. Wang, Shuai McGuire, Darren K. Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial |
| title | Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial |
| title_full | Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial |
| title_fullStr | Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial |
| title_full_unstemmed | Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial |
| title_short | Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial |
| title_sort | cardiorenal outcomes with ertugliflozin by baseline metformin use: post hoc analyses of the vertis cv trial |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390228/ https://www.ncbi.nlm.nih.gov/pubmed/35994565 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.058294 |
| work_keys_str_mv | AT cosentinofrancesco cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT cannonchristopherp cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT frederichrobert cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT cherneydavidzi cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT dagogojacksamuel cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT pratleyricharde cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT mancusojamesp cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT maldonadomario cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT caternilob cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT wangshuai cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial AT mcguiredarrenk cardiorenaloutcomeswithertugliflozinbybaselinemetforminuseposthocanalysesofthevertiscvtrial |